Buy or sell Mendel Biotechnology stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Acquired
Mendel Biotechnology Stock
Mendel Biotechnology is a plant biotechnology company that develops genetic and chemical solutions for a range of agricultural markets.
About Mendel Biotechnology Stock
Mendel Biotechnology, Inc. operates as a plant biotechnology company. The company focuses on developing genetic and chemical solutions for a range of agricultural markets. It offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company has strategic partnerships with Monsanto Corporation, BP, and Bayer CropScience. Mendel Biotechnology, Inc. was founded in 1997 and is based in Hayward, California. It has operations in the United States, Europe, and China.
Funding History
| June 2007 | $8.4M |
|---|---|
| November 2011 | $11.8M |
Management
Sr. Vice President, Corporate Development
Greg Ikonen
Sr. Vice President, Research
Oliver J. Ratckliffe
Director, Computational Biology
Don Maszle
Director, Research
T.Lynne Reuber
Sr. Director, Research
Joshua Armstrong
Chief Financial Officer
Susan Berland
Director, Research
Peter Repetti
President and Chief Executive Officer
Neal Gutterson
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
